Horak W
Acta Med Austriaca Suppl. 1975;4:1-38.
Although chemistry and physiology of bile acids have been elucidated during the last two decades, tests concerning bile acid metabolism are still rarely used in clinical medicine. The aim of this study therefore was, to investigate bile acid metabolism in patients with liver diseases and to find prognostic valuable parameters which can be recommended for clinical use. Following an introducing review of biosynthesis and kinetics of bile acids, normal values are presented for pool size and synthesis of the two primary bile acids, for bile lipid composition, plasma bile acid concentration and for clearance and conjugation of intravenously injected 14C-cholic acid, which have been measured in healthy subjects. Bile acids were determined by thin-layer-chromatography, gas-liquid-chromatography and by an enzymatic and fluorimetric method. In all patients investigated with acute hepatic necrosis, plasma disappearance of radioactivity was greatly prolonged after intravenous injection of 14C-cholic acid. By estimating free 14C-cholic acid and 14C-cholic acid conjugates in plasma individually, two groups of patients could be distinguished: in patients who survived hepatic coma, the clearance of free 14C-cholic acid was significantly more rapid and the percentage of glycine and taurine conjugates of 14C-cholic acid in plasma was significantly higher than in patients who died in coma. This prognostic significant differentiation was possible by measuring the relationship of conjugated: unconjugated radioactivity in one single plasma sample taken three hours after injection. In patients with cirrhosis of the liver the plasma disappearance rate of radioactivity during 60 minutes following injection of 14C-cholic acid was significantly correlated with serum-bilirubin, SGOT, serum-albumin, prothrombine-time, plasma bile acids, and a clinical scoring. 14C-deoxycholic acid was found in plasma of only a few patients 24 hours after injection of the labelled cholic acid, and was related to the relatively good liver function in these patients. It is concluded that the following tests of bile acid metabolism are of clinical interest: 1. Measuring plasma bile acid concentration may serve as a sensitive liver function test. 2. Estimation of the conjugation of intravenously injected 14C-cholic acid is of prognostic value in patients with fulminant hepatic failure. 3. Determination of the initial plasma disappearance rate of 14C-cholic acid injected intravenously and its transformation to 14C-cholic acid injected intravenously and its transformation to 14C-deoxycholic acid may help to classify patients with cirrhosis of the liver.
尽管在过去二十年中胆汁酸的化学和生理学已被阐明,但有关胆汁酸代谢的检测在临床医学中仍很少使用。因此,本研究的目的是调查肝病患者的胆汁酸代谢,并找到可推荐用于临床的具有预后价值的参数。在对胆汁酸的生物合成和动力学进行介绍性综述之后,给出了在健康受试者中测量的两种初级胆汁酸的池大小和合成、胆汁脂质组成、血浆胆汁酸浓度以及静脉注射14C-胆酸的清除和结合的正常值。胆汁酸通过薄层色谱法、气液色谱法以及酶促和荧光法测定。在所有接受急性肝坏死调查的患者中,静脉注射14C-胆酸后,血浆放射性的消失大大延长。通过分别估计血浆中游离的14C-胆酸和14C-胆酸结合物,可以区分两组患者:在肝昏迷存活的患者中,游离14C-胆酸的清除明显更快,血浆中14C-胆酸的甘氨酸和牛磺酸结合物的百分比明显高于在昏迷中死亡的患者。通过测量注射后三小时采集的单个血浆样本中共轭:未共轭放射性的关系,可以进行这种具有预后意义的区分。在肝硬化患者中,注射14C-胆酸后60分钟内血浆放射性的消失率与血清胆红素、谷草转氨酶、血清白蛋白、凝血酶原时间、血浆胆汁酸以及临床评分显著相关。在注射标记胆酸24小时后,仅在少数患者的血浆中发现了14C-脱氧胆酸,并且与这些患者相对良好的肝功能有关。结论是,以下胆汁酸代谢检测具有临床意义:1. 测量血浆胆汁酸浓度可作为一种敏感的肝功能检测。2. 估计静脉注射14C-胆酸的结合在暴发性肝衰竭患者中具有预后价值。3. 测定静脉注射的14C-胆酸的初始血浆消失率及其向14C-脱氧胆酸的转化可能有助于对肝硬化患者进行分类。